David A. Siegel Edwards Lifesciences Corp Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 33,003 shares of EW stock, worth $2.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

33,003

Holding current value

$2.47 Million

% of portfolio

0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $1.97 Million - $3.1 Million	33,003 New	33,003 $2.18 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $91.8 Million - $121 Million	-1,265,197 Reduced 85.85%	208,506 $19.9 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $6.31 Million - $7.95 Million	-102,200 Reduced 6.49%	1,473,703 $112 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $12 Million - $16.1 Million	-172,500 Reduced 9.87%	1,575,903 $109 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $70.6 Million - $81.8 Million	-866,800 Reduced 33.14%	1,748,403 $165 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $66 Million - $75.1 Million	-888,600 Reduced 25.36%	2,615,203 $216 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $148 Million - $189 Million	2,164,100 Added 161.54%	3,503,803 $261 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $23.2 Million - $30.2 Million	281,900 Added 26.65%	1,339,703 $111 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $9.4 Million - $13.9 Million	-108,700 Reduced 9.32%	1,057,803 $101 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $72.5 Million - $91.3 Million	-711,500 Reduced 37.89%	1,166,503 $137 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $6.99 Million - $8.59 Million	65,700 Added 3.63%	1,878,003 $243 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $132 Million - $158 Million	1,287,400 Added 245.26%	1,812,303 $205 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $21.4 Million - $26.8 Million	255,500 Added 94.84%	524,903 $54.4 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $21.2 Million - $24.4 Million	269,403 New	269,403 $22.5 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $3.28 Million - $4.18 Million	-45,815 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $123 Million - $160 Million	-1,825,794 Reduced 97.55%	45,815 $3.66 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $89.4 Million - $120 Million	1,553,306 Added 488.0%	1,871,609 $129 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $15.2 Million - $23.4 Million	-289,200 Reduced 47.6%	318,303 $60 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $25.1 Million - $28.8 Million	350,700 Added 136.56%	607,503 $142 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $713,980 - $874,988	11,600 Added 4.73%	256,803 $56.5 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $13.7 Million - $15.8 Million	245,203 New	245,203 $45.3 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $5.33 Million - $6.54 Million	-114,887 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $6.08 Million - $7.72 Million	-133,002 Reduced 53.65%	114,887 $20 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $21.7 Million - $26.3 Million	-511,800 Reduced 67.37%	247,889 $36.1 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $3.55 Million - $4.53 Million	-95,500 Reduced 11.17%	759,689 $106 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $25.8 Million - $30.1 Million	763,000 Added 827.65%	855,189 $96.4 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $3.35 Million - $3.58 Million	92,189	92,189 $10.1 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account